Markets /ATBPF Antibe Therapeutics Inc. ATBPF Full chart Compare Add to watchlist Set alert Price alert · ATBPF Alert when the price is Price abovePrice below Price level Set alert All alert types 0.22 +0.22 Day range unavailable 52-week range unavailable Overview Chart Financials FinancialsValuation & healthEarnings EarningsDividends & splitsAnalysts News Ownership Options More ComparisonSignalsTrend ScoreDiscussionNotesPositionsAlerts FinancialsValuation & health Revenue history · Free cash flow history OverviewIncome statementBalance sheetCash flow Revenue & Expenses AnnualQuarterly FY 2021FY 2020FY 2019 Other Operating Income → Expenses: $2.31MExpenses → Selling, General & Admin: $10.10MExpenses → Research & Development: $15.73MExpenses → Interest Expense: $6.37KExpenses → Other Expenses: $4.51MExpenses → Income Tax: $1.80MGross Profit → Expenses: $3.55MRevenue → Gross Profit: $3.55MRevenue → Cost of Revenue: $6.16MNet Loss → Expenses: $26.30MOther Operating Income$2.31MGross Profit$3.55MNet Loss$26.30MCost of Revenue$6.16MExpenses$32.16MSelling, General & Admin$10.10MResearch & Development$15.73MInterest Expense$6.37KOther Expenses$4.51MIncome Tax$1.80MRevenue$9.71M No annual statement lines ATBPF has no annual lines for this statement.
